A new compound, mucic acid 3-O-gallate (1), was isolated from the fruit of Phyllanthus emblica L, together with 5 known compounds (2-6). Their structures were elucidated on the basis of spectroscopic analysis, including 1D and 2D NMR techniques, and by comparison with literature data.
The genus Phyllanthus (Euphorbiaceae) is widely distributed throughout tropical and subtropical countries. P. emblica L. has been used as a traditional Tibetan medicine for the treatment of different types of diseases (for example, hypertension, hepatitis, blood stasis, and pharyngitis). It was reported that the fruit possesses anti-cancer, anti-mutation, anti-oxidation, anti-bacterial, anti-virus, anti-inflammatory, anti-atherosclerosis and lipid reduction effects, and is rich in mucic acids [1] [2] [3] [4] . As part of our phytochemical investigation of medicinal plants for the discovery of new bioactive natural products, we report the isolation from the fruit of P. emblica and structural determination of one new phenolic compound, mucic acid-3-O-gallate (1), together with five known compounds, mucic acid 2-O-gallate (2), mucic acid 1,4lactone-3-O-gallate (3), 1,4-lactone-5-O-gallate (4), mucic acid (5) and quercetin-3-O--D-rhamnoside (6).
The dry fruit material of P. emblica was repeatedly extracted with 60% aqueous acetone at room temperature. The extract was concentrated and partitioned with EtOAc. The water fraction was separated by column chromatography on Dianion HP 20P, Toyopearl HW-40, Sephadex LH-20, and MCI gel CHP 20P to obtain compounds 1-5. A similar procedure yielded compound 6 from the EtOAc fraction. 
